You have no items in your shopping cart.
On Promotion 
Tested Applications
Reactivity
Predicted Reactivity
Conjugation
Biologically Active
Featured Product
Recombinant Mouse CD116/CSF2RA Protein, N-His [orb2963735]>90% as determined by SDS-PAGE.
31.19 kDa
1 mg, 100 μg, 50 μg- Recombinant Human CSF2/GM-CSF Protein, C-His [orb2963974]
>90% as determined by SDS-PAGE.
16 kDa
1 mg, 100 μg, 50 μg 
CSF2/GM-CSF Polyclonal Antibody [orb2955696]ELISA, IHC, WB
Human
Rabbit
Polyclonal
Unconjugated
100 μg, 50 μg- Recombinant Pig CSF2/GM-CSF Protein, N-His [orb2966265]
>90% as determined by SDS-PAGE.
16.68 kDa
1 mg, 100 μg, 50 μg - Recombinant Mouse CSF2/GM-CSF Protein, C-His [orb2966266]
>90% as determined by SDS-PAGE.
17.06 kDa
1 mg, 100 μg, 50 μg - Rat GM-CSF [orb3002300]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.6 KDa. Observed: 17-25 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human GM-CSF [orb3002416]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.5 KDa. Observed: 17-30 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Mouse GM-CSF [orb3002464]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.1 KDa. Observed: 18-30 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human GM-CSF [orb3002484]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC. (Regularly tested)
Predicted: 14.6 KDa. Observed: 13-17 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg